Search Results

BioMidwest

Omega Laboratories Achieves SAMHSA Accreditation

Omega Laboratories, Inc. announces that its state-of-the-art laboratory in Ontario, Canada has received Substance Abuse and Mental Health Services Administration accreditation from the National Laboratory Certification Program.

October 17, 2023

·

3 min read

Business

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

Omega Therapeutics, Inc. today announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders.

June 24, 2024

·

6 min read

Genetown

Omega Therapeutics To Participate In Two Upcoming Investor Conferences - May 30, 2024

Omega Therapeutics, Inc. today announced that management will participate in fireside chats at two upcoming investor conferences.

May 30, 2024

·

1 min read

Business

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

Omega Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, announced the appointment of Kaan Certel, Ph.D., as Chief Business Officer.

May 29, 2024

·

6 min read

Business

Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

Omega Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and highlighted recent Company progress.

May 6, 2024

·

10 min read

BioMidwest

Omega Laboratories Achieves ISO 17025 Accreditation at Ontario, Canada Laboratory

Omega Laboratories, a leading provider of laboratory testing solutions, is proud to announce that its toxicology laboratory in Ontario, Canada, has been awarded ISO 17025 accreditation.

May 31, 2023

·

2 min read

Genetown

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that U.K.-based Rothamsted Research Limited has granted to the Company an exclusive global, commercial license to advanced technology for producing sustainable omega-3 products in Camelina sativa.

June 17, 2024

·

7 min read

Business

Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”) today announced financial results for the fourth quarter and full year ended December 31, 2023, and a strategic prioritization initiative to focus resources on near-term milestones to support long-term shareholder value.

March 28, 2024

·

14 min read

Press Releases

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

October 15, 2024

·

5 min read

Deals

Juno Pharmaceuticals Acquires Omega Laboratories, Propelling Canada’s Pharmaceutical Industry Forward

Today, Juno Pharmaceuticals Canada announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers.

May 15, 2023

·

3 min read